NCT01270373 - NeoSAMBA: Neoadjuvant: Does the Sequence of Anthracycline and Taxane Matters: Before or After? | Biotech Hunter

Enrollment

112

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

April 30, 2020

Study Completion Date

June 30, 2020

Conditions

Breast Cancer

Interventions

DRUG

FAC x 3 followed by Docetaxel x 3

5-Fluorouracil (500 mg/m2), Doxorubicin (50 mg/m2) and Cyclophosphamide (500 mg/m2) IV every 21 days, for 3 cycles; followed by Docetaxel 100 mg/m2 every 21 days, for 3 cycles

DRUG

Docetaxel x 3 followed by FAC x 3

Docetaxel 100 mg/m2 IV every 21 days, for 3 cycles; followed by 5-Fluorouracil (500 mg/m2), Doxorubicin (50 mg/m2) and Cyclophosphamide (500 mg/m2) IV every 21 days, for 3 cycles

Trial Locations (1)

20560-120

Hospital do Cancer III, Rio de Janeiro